久坐时间变化对合并2型糖尿病的外周动脉疾病患者监督下运动疗法效果的影响
本试点研究纳入44例启动12周监督下运动疗法(SET)的PAD患者,用加速度计评估久坐行为并完成6分钟步行试验等指标。结果显示SET期间久坐时间平均无明显变化但个体差异大,合并T2DM者跛行起始距离改善更明显;久坐时间变化与6分钟步行距离变化无关。
要点
- SET期间久坐时间平均未变,但个体波动大,需关注其变化
- 合并T2DM者跛行起始距离改善优于无T2DM者
- 久坐时间变化未预测6分钟步行总距离的改善
核心结论
- SET期间久坐时间平均无变化,其变化未预测6分钟步行总距离改善;合并T2DM者跛行起始距离改善更明显。
研究设计与样本
- 试点研究,纳入44例启动12周SET的PAD患者(含与不含T2DM),在基线、6周和12周评估。
主要发现
- 平均久坐时间在SET后无变化,但变化范围达-40%至+38%。
- 合并T2DM者跛行起始距离改善大于无T2DM者(均值35 m,P=0.044,95%CI 1.6至115.4 m)。
- 基线至6周久坐时间变化(P=0.419)与T2DM(P=0.154)均未预测基线至12周6分钟步行总距离变化。
临床怎么用
- 对合并T2DM的PAD患者行SET时,可预期其跛行起始距离改善更明显,但仍需探索影响SET反应的因素。
局限性
- 为试点研究,样本量n=44,结果需更大样本验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Although supervised exercise therapy (SET) is effective in improving walking distance among adults with symptomatic peripheral artery disease (PAD), some research suggests that individuals with comorbid PAD and type 2 diabetes mellitus (T2DM) may experience a blunted response to SET. It is unknown whether free-living sedentary time changes during SET, and if increases in sedentary time could, in part, explain poor response to SET. The purposes of this pilot study were to (1) determine if older adults with PAD (with and without T2DM) engaging in SET change their sedentary behavior and (2) examine the relationship between changes in sedentary behavior and SET outcomes. We hypothesized that decreased sedentary time during SET would be associated with greater improvements in six-minute walk test (6MWT) total distance and other key SET outcomes. METHODS: Participants (n = 44) initiating a 12-week SET program completed the 6MWT, Short Physical Performance Battery, Walking Impairment Questionnaire, and accelerometer-assessed sedentary behavior at SET initiation, 6 weeks, and 12 weeks. RESULTS: Participants' mean age was 72.3 (7.1) years, mean ankle-brachial index was 0.71 (0.25), and 47.7% were female. On average, sedentary time did not change after SET, although there was substantial variability (-40% to +38% change in minutes of sedentary time/day). Participants with T2DM experienced greater improvements in claudication onset distance than participants without T2DM (mean = 35 m, P = 0.044, 95% confidence interval = 1.6 to 115.4 m). Neither changes in sedentary time from baseline to 6 weeks (P = 0.419) nor T2DM (P = 0.154) predicted changes in 6MWT total distance from baseline to 12 weeks. CONCLUSIONS: As SET availability increases, further examination of factors that may influence SET outcomes will help maximize benefits of this proven therapy.
引用
- Whipple MO, Schorr EN, Talley KMC, et al. Influence of Changes in Sedentary Time on Outcomes of Supervised Exercise Therapy in Individuals with Comorbid Peripheral Artery Disease and Type 2 Diabetes. Ann Vasc Surg. 2020. PMID: 32278867. doi:10.1016/j.avsg.2020.03.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。